Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.227
Delayed Data
As of 4:01pm ET
 -0.007 / -2.99%
Today’s Change
0.21
Today|||52-Week Range
0.42
-9.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues36.0K76.0K36.0K45.0K
 
 
 
 
 
Cost of Goods Sold113.0K157.0K18.0K153.0K
 
 
 
 
 
Depreciation And Amortization43.0K332.0K276.0K306.0K
 
 
 
 
 
 
Operating ExpensesGross Income-120.0K-413.0K-258.0K-414.0K
 
 
 
 
 
General Expenses3.3M4.7M4.8M3.9M
 
 
 
 
 
Research And Development1.5M2.3M2.3M1.9M
 
 
 
 
 
Total Operating Expenses3.4M5.2M5.1M4.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M-5.1M-5.1M-4.3M
 
 
 
 
 
Extraordinary Credit52.0K0.001.0K--
 
 
 
Interest Expense On Debt15.0K3.0K3.0K3.0K
 
 
 
 
 
Other Expenses0.001.1M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.2M-3.8M-5.0M-4.2M
 
 
 
 
 
Net Income-3.2M-3.8M-5.0M-4.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS159.8M176.7M185.7M190.7M
 
 
 
 
 
Shares To Calculate EPS Diluted159.8M176.7M185.7M190.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.03-$0.02
 
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.03-$0.02
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account